StonvexLoading…
StonvexCore line items from MAS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.92B | $7.56B | $5.77B | $3.85B |
Operating Income | $316.00M | $1.25B | $1.00B | $698.00M |
Net Income | $213.00M | $810.00M | $645.00M | $456.00M |
EPS (Diluted) | $1.05 | $3.86 | $3.06 | $2.15 |
Total Assets | $5.23B | $5.20B | $5.31B | $5.29B |
Total Liabilities | $5.21B | $5.13B | $5.14B | $5.14B |
Cash & Equivalents | $388.00M | $647.00M | $559.00M | $390.00M |
Free Cash Flow OCF − CapEx | $-113.00M | $866.00M | $495.00M | $80.00M |
Shares Outstanding | 201.70M | 204.30M | 207.70M | 209.40M |